GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » NonCurrent Deferred Liabilities

NuCana (NuCana) NonCurrent Deferred Liabilities : $0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is NuCana NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

NuCana's non-current deferred liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

NuCana NonCurrent Deferred Liabilities Historical Data

The historical data trend for NuCana's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana NonCurrent Deferred Liabilities Chart

NuCana Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only - - - - -

NuCana Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NuCana NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of NuCana's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


NuCana (NuCana) Business Description

Industry
Traded in Other Exchanges
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.